164 related articles for article (PubMed ID: 23211099)
1. Identification of new potent GPR119 agonists by combining virtual screening and combinatorial chemistry.
Wellenzohn B; Lessel U; Beller A; Isambert T; Hoenke C; Nosse B
J Med Chem; 2012 Dec; 55(24):11031-41. PubMed ID: 23211099
[TBL] [Abstract][Full Text] [Related]
2. Use of small-molecule crystal structures to address solubility in a novel series of G protein coupled receptor 119 agonists: optimization of a lead and in vivo evaluation.
Scott JS; Birch AM; Brocklehurst KJ; Broo A; Brown HS; Butlin RJ; Clarke DS; Davidsson O; Ertan A; Goldberg K; Groombridge SD; Hudson JA; Laber D; Leach AG; Macfaul PA; McKerrecher D; Pickup A; Schofield P; Svensson PH; Sörme P; Teague J
J Med Chem; 2012 Jun; 55(11):5361-79. PubMed ID: 22545772
[TBL] [Abstract][Full Text] [Related]
3. New potential antihistaminic compounds. Virtual combinatorial chemistry, computational screening, real synthesis, and pharmacological evaluation.
Duart MJ; Antón-Fos GM; Alemán PA; Gay-Roig JB; González-Rosende ME; Gálvez J; García-Domenech R
J Med Chem; 2005 Feb; 48(4):1260-4. PubMed ID: 15715494
[TBL] [Abstract][Full Text] [Related]
4. From astemizole to a novel hit series of small-molecule somatostatin 5 receptor antagonists via GPCR affinity profiling.
Guba W; Green LG; Martin RE; Roche O; Kratochwil N; Mauser H; Bissantz C; Christ A; Stahl M
J Med Chem; 2007 Dec; 50(25):6295-8. PubMed ID: 18020391
[TBL] [Abstract][Full Text] [Related]
5. A practical use of ligand efficiency indices out of the fragment-based approach: ligand efficiency-guided lead identification of soluble epoxide hydrolase inhibitors.
Tanaka D; Tsuda Y; Shiyama T; Nishimura T; Chiyo N; Tominaga Y; Sawada N; Mimoto T; Kusunose N
J Med Chem; 2011 Feb; 54(3):851-7. PubMed ID: 21192659
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationships of a series of 3-aryl-4-isoxazolecarboxamides as a new class of TGR5 agonists.
Budzik BW; Evans KA; Wisnoski DD; Jin J; Rivero RA; Szewczyk GR; Jayawickreme C; Moncol DL; Yu H
Bioorg Med Chem Lett; 2010 Feb; 20(4):1363-7. PubMed ID: 20097073
[TBL] [Abstract][Full Text] [Related]
7. Optimization of oxadiazole derivatives with a spirocyclic cyclohexane structure as novel GPR119 agonists.
Harada K; Mizukami J; Watanabe T; Mori G; Ubukata M; Suwa K; Fukuda S; Negoro T; Sato M; Inaba T
Bioorg Med Chem Lett; 2019 Aug; 29(16):2100-2106. PubMed ID: 31288965
[TBL] [Abstract][Full Text] [Related]
8. Discovery and optimization of 5-(2-((1-(phenylsulfonyl)-1,2,3,4-tetrahydroquinolin-7-yl)oxy)pyridin-4-yl)-1,2,4-oxadiazoles as novel gpr119 agonists.
Wang Y; Yu M; Zhu J; Zhang JK; Kayser F; Medina JC; Siegler K; Conn M; Shan B; Grillo MP; Liu JJ; Coward P
Bioorg Med Chem Lett; 2014 Feb; 24(4):1133-7. PubMed ID: 24440299
[TBL] [Abstract][Full Text] [Related]
9. Discovery of 5-phenoxy-1,3-dimethyl-1H-pyrazole-4-carboxamides as potent agonists of TGR5 via sequential combinatorial libraries.
Londregan AT; Piotrowski DW; Futatsugi K; Warmus JS; Boehm M; Carpino PA; Chin JE; Janssen AM; Roush NS; Buxton J; Hinchey T
Bioorg Med Chem Lett; 2013 Mar; 23(5):1407-11. PubMed ID: 23337601
[TBL] [Abstract][Full Text] [Related]
10. The synergy between combinatorial chemistry and high-throughput screening.
Diller DJ
Curr Opin Drug Discov Devel; 2008 May; 11(3):346-55. PubMed ID: 18428088
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of isoxazole, oxazole, and oxadiazole containing heteroaryl analogs of biaryl ureas as DGAT1 inhibitors.
Jadhav RD; Kadam KS; Kandre S; Guha T; Reddy MM; Brahma MK; Deshmukh NJ; Dixit A; Doshi L; Potdar N; Enose AA; Vishwakarma RA; Sivaramakrishnan H; Srinivasan S; Nemmani KV; Gupte A; Gangopadhyay AK; Sharma R
Eur J Med Chem; 2012 Aug; 54():324-42. PubMed ID: 22683241
[TBL] [Abstract][Full Text] [Related]
12. Discovery of orally bioavailable and novel urea agonists of the high affinity niacin receptor GPR109A.
Shen HC; Szymonifka MJ; Kharbanda D; Deng Q; Carballo-Jane E; Wu KK; Wu TJ; Cheng K; Ren N; Cai TQ; Taggart AK; Wang J; Tong X; Waters MG; Hammond ML; Tata JR; Colletti SL
Bioorg Med Chem Lett; 2007 Dec; 17(24):6723-8. PubMed ID: 18029181
[TBL] [Abstract][Full Text] [Related]
13. Discovery and optimization of arylsulfonyl 3-(pyridin-2-yloxy)anilines as novel GPR119 agonists.
Zhang JK; Li AR; Yu M; Wang Y; Zhu J; Kayser F; Medina JC; Siegler K; Conn M; Shan B; Grillo MP; Eksterowicz J; Coward P; Liu JJ
Bioorg Med Chem Lett; 2013 Jun; 23(12):3609-13. PubMed ID: 23648181
[TBL] [Abstract][Full Text] [Related]
14. Novel 2D fingerprints for ligand-based virtual screening.
Ewing T; Baber JC; Feher M
J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
[TBL] [Abstract][Full Text] [Related]
15. Pharmacophore identification, in silico screening, and virtual library design for inhibitors of the human factor Xa.
Krovat EM; Frühwirth KH; Langer T
J Chem Inf Model; 2005; 45(1):146-59. PubMed ID: 15667140
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of non-peptidic cyclophilin ligands.
Wu YQ; Belyakov S; Choi C; Limburg D; Thomas IV BE; Vaal M; Wei L; Wilkinson DE; Holmes A; Fuller M; McCormick J; Connolly M; Moeller T; Steiner J; Hamilton GS
J Med Chem; 2003 Mar; 46(7):1112-5. PubMed ID: 12646018
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationships of 3,5-diarylisoxazoles and 3,5-diaryl-1,2,4-oxadiazoles, novel classes of small molecule interleukin-8 (IL-8) receptor antagonists.
Weidner-Wells MA; Henninger TC; Fraga-Spano SA; Boggs CM; Matheis M; Ritchie DM; Argentieri DC; Wachter MP; Hlasta DJ
Bioorg Med Chem Lett; 2004 Aug; 14(16):4307-11. PubMed ID: 15261292
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationship of dihydrobenzofuran derivatives as novel human GPR119 agonists.
Ye XY; Morales CL; Wang Y; Rossi KA; Malmstrom SE; Abousleiman M; Sereda L; Apedo A; Robl JA; Miller KJ; Krupinski J; Wacker DA
Bioorg Med Chem Lett; 2014 Jun; 24(11):2539-45. PubMed ID: 24755425
[TBL] [Abstract][Full Text] [Related]
19. Hsp90 inhibitors and drugs from fragment and virtual screening.
Roughley S; Wright L; Brough P; Massey A; Hubbard RE
Top Curr Chem; 2012; 317():61-82. PubMed ID: 21647838
[TBL] [Abstract][Full Text] [Related]
20. Novel technologies for virtual screening.
Lengauer T; Lemmen C; Rarey M; Zimmermann M
Drug Discov Today; 2004 Jan; 9(1):27-34. PubMed ID: 14761803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
